Dr Reddys Laboratories RDY
NYSE RDY
$12.85 +0.34 (+2.68%)
As of: Sep 29, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Total Debt (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) recorded Total Debt of $785.15 million in the quarter ended Jun 30, 2026, up 54.3% from $508.85 million a year earlier but down 13.9% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Total Debt (2009 - 2026) Analysis & Trends

As of Mar 31, 2026, Dr Reddys Laboratories reported Total Debt of $824 million, up 50.6% from the prior year.

  • Annual Total Debt has a five-year compound annual growth rate of 14.8% (years ended Mar 2021 to Mar 2026).
  • Across earlier years, Total Debt came in at $547 million in the year ended Mar 31, 2025 (+127.0%), $241 million in the year ended Mar 31, 2024 (-22.8%), $312 million in the year ended Mar 31, 2023 (-30.0%) and $446 million in the year ended Mar 31, 2022 (+7.7%).
  • Quarterly Total Debt has ranged from $163.88 million in the quarter ended Mar 31, 2023 to $911.71 million in the quarter ended Mar 31, 2026 over the past five years.
  • On a year-over-year basis, Total Debt has increased for ten consecutive quarters, with growth averaging 90.1% over the last eight quarters.
  • Peak year-over-year performance for Total Debt in the last five years was growth of 228.7% in the quarter ended Sep 30, 2024, against a decline of 63.6% in the quarter ended Mar 31, 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $911.71 million (quarter ended Mar 31, 2026), $826.15 million (quarter ended Dec 31, 2025) and $671.13 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Dr Reddys Laboratories 10.44 Bn 9.62 Bn 396.53 Mn 785.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 785.15 Mn
Mar 31, 2026 911.71 Mn
Dec 31, 2025 826.15 Mn
Sep 30, 2025 671.13 Mn
Jun 30, 2025 508.85 Mn
Mar 31, 2025 540.06 Mn
Dec 31, 2024 605.03 Mn
Sep 30, 2024 579.00 Mn
Jun 30, 2024 367.72 Mn
Mar 31, 2024 241.07 Mn
Dec 31, 2023 238.41 Mn
Sep 30, 2023 176.16 Mn
Jun 30, 2023 245.38 Mn
Mar 31, 2023 163.88 Mn
Dec 31, 2022 272.84 Mn
Sep 30, 2022 276.03 Mn
Jun 30, 2022 596.20 Mn
Mar 31, 2022 450.11 Mn
Dec 31, 2021 386.57 Mn
Sep 30, 2021 420.93 Mn
API Access

Dr Reddys Laboratories Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=RDY&period=max&api_key=YOUR_API_KEY